If you need more lookups,
subscriptions start at $34 USD/month.
Catherine F. Location
Boston, MA, US
Catherine F. Work
Head of Scientific Affairs @ (September 2026 - Present)
Executive Director, Medical Affairs @ (August 2025 - June 2026)
Senior Director, Medical Affairs @ Cerevel Therapeutics & AbbVie (April 2022 - August 2025)
Medical Director, Alzheimer’s Disease @ (March 2020 - April 2022)
Field Lead, Neuroscience MSL Team @ (January 2012 - March 2020)
Regional Scientific Director (Principal MSL) @ (March 2008 - January 2012)
Regional Scientific Associate Director (Sr. MSL) @ (March 2004 - March 2008)
Regional Scientific Manager (MSL) @ (June 2003 - March 2004)
Consultant - Life Sciences Corridor @ (January 2002 - January 2003)
Sr. Scientist and Director, Animal Vivarium @ Esperion Therapeutics (January 2000 - January 2002)
Catherine F. Education
MIT Professional Education
UW School of Medicine and Public Health
Doctor of Philosophy - PhD
University of Michigan
BS
University of Michigan Medical School
post-doctoral fellowship
Yale School of Medicine
post-doctoral fellowship
Catherine F. Skills
Biotechnology
Cardiology
Clinical Development
Clinical Trials
Diabetes
Drug Development
Field Medical Strategy
Infectious Diseases
Life Sciences
Medical Affairs
Medical Communications
Medical Education
Medical Writing
Neuroanatomy
Neurology
Neuropathology
Neuroscience
Neuroscience product launch planning
Oncology
Osteoporosis
Pharmaceutical Industry
Product Launch
Psychiatry
Startups
Catherine F. Summary
Catherine F., based in Boston, MA, US, is currently a Head of Scientific Affairs at Sironax. Catherine F. brings experience from previous roles at Intra-Cellular Therapies, Cerevel Therapeutics & AbbVie, Biogen and Genentech. Catherine F. holds a MIT Professional Education. With a robust skill set that includes Biotechnology, Cardiology, Clinical Development, Clinical Trials, Diabetes and more. Catherine F. has 3 emails on RocketReach.
Looking for a different Catherine F.?
Find contact details for 700 million professionals.